Eupraxia Pharmaceuticals is trading 5.49% up at $8.46 as major U.S. indexes rise more than 1% following August CPI data, supporting broader risk appetite [Event ID: 6aa3f9556bd24fae9956489b].
- Shares are outperforming the September 10 close of $8.02.
- Management is scheduled to participate in a Cantor Global Healthcare Conference fireside chat on September 11, 2026, at 9:45 a.m. ET.
- No new company-specific clinical, earnings, or regulatory catalyst was identified.